Versor Investments’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Sell |
3,003
-2,671
| -47% | -$199K | 0.04% | 631 |
|
|
2025
Q1 | $361K | Buy |
+5,674
| New | +$361K | 0.06% | 506 |
|
|
2024
Q4 | – | Sell |
-3,600
| Closed | -$289K | – | 844 |
|
|
2024
Q3 | $289K | Buy |
3,600
+300
| +9% | +$24.1K | 0.05% | 598 |
|
|
2024
Q2 | $273K | Buy |
+3,300
| New | +$273K | 0.05% | 552 |
|
|
2024
Q1 | – | Sell |
-7,921
| Closed | -$677K | – | 766 |
|
|
2023
Q4 | $677K | Sell |
7,921
-44
| -0.6% | -$3.76K | 0.14% | 233 |
|
|
2023
Q3 | $714K | Buy |
7,965
+3,639
| +84% | +$326K | 0.14% | 197 |
|
|
2023
Q2 | $368K | Sell |
4,326
-1,993
| -32% | -$170K | 0.06% | 356 |
|
|
2023
Q1 | $523K | Sell |
6,319
-5,281
| -46% | -$437K | 0.07% | 313 |
|
|
2022
Q4 | $912K | Buy |
11,600
+7,009
| +153% | +$551K | 0.08% | 171 |
|
|
2022
Q3 | $340K | Buy |
+4,591
| New | +$340K | 0.02% | 564 |
|
|
2019
Q1 | – | Sell |
-2,157
| Closed | -$216K | – | 291 |
|
|
2018
Q4 | $216K | Sell |
2,157
-2,600
| -55% | -$260K | 0.05% | 251 |
|
|
2018
Q3 | $545K | Buy |
4,757
+100
| +2% | +$11.5K | 0.2% | 145 |
|
|
2018
Q2 | $418K | Hold |
4,657
| – | – | 0.14% | 188 |
|
|
2018
Q1 | $341K | Buy |
+4,657
| New | +$341K | 0.11% | 196 |
|